#South Korea #Seoul #AHA #Sky Labs #Clinical Hypertension

Sky Labs Commits to Supporting Clinical Hypertension Research

On March 12, 2026, Sky Labs, a pioneering AI healthcare company, made a significant announcement regarding its support for the "Established Investigator Award for Clinical Hypertension" initiated by the American Heart Association (AHA). This support comes as part of a collaborative effort following a Memorandum of Understanding signed with the AHA last September, which is expected to advance hypertension research on a global scale.

The Established Investigator Award aims to provide substantial funding to three distinguished researchers who have made extraordinary contributions to hypertension research between 2026 and 2028. Sky Labs is set to contribute around $90,000 for this purpose, which will cover the annual fees for the selected researchers along with all necessary program operating costs.

Eligibility for the award includes membership in the Scientific Council on Hypertension of the AHA, reflecting the organization’s high standards for recognizing outstanding achievements in hypertension studies.

Jack Byunghwan Lee, the CEO of Sky Labs, expressed the company's pride in supporting the AHA, stating, "It is a great honor for us to back the American Heart Association and contribute to world-class hypertension research outcomes. We will intensify clinical research to validate the effectiveness of blood pressure management solutions, while simultaneously committing to ongoing research and development to bolster these important initiatives."

Innovative Solutions by Sky Labs

Sky Labs is renowned for its innovative healthcare solutions, leveraging artificial intelligence to manage chronic diseases effectively. The company is best known for its groundbreaking device, "CART," which is the world's first medical-grade wearable blood pressure monitor in the form of a ring.

Founded in September 2015, Sky Labs has developed and managed CART and its accompanying patient monitoring platform targeting individuals with chronic illnesses. The journey began with the initial version of CART launched in 2020, which monitored atrial fibrillation using cardiac signals from optical sensors. Since then, the company has expanded its technological capabilities significantly.

In 2023, Sky Labs received medical device approval for its product "CART BP pro," a ring-shaped monitor designed to measure blood pressure over a 24-hour period. By 2024, the CART BP pro gained recognition from the Health Insurance Review and Assessment Service (HIRA), allowing it to be prescribed in hospitals and clinics throughout Korea as part of an established outpatient blood pressure monitoring procedure.

In September 2025, Sky Labs launched "CART BP," a consumer-focused blood pressure monitoring ring, which is available via its official online store and other various online channels, further solidifying its commitment to enhancing public health through innovative technology.

Sky Labs' contribution to the Established Investigator Award is a critical step toward fostering further research into hypertension, an increasingly prevalent health issue. The company’s dedication not only underscores its commitment to advancing medical science but also highlights its role in facilitating partnerships that promote health innovations.

With the support of organizations like Sky Labs, the American Heart Association can continue to fund vital research that has the potential to improve health outcomes for millions of people suffering from hypertension. As the landscape of healthcare continues to evolve, initiatives like these are essential in prioritizing effective treatment and management solutions for chronic conditions.